GLP-1 Agonist Use Leads to Earlier Return of Bowel Function Following Lumbar Fusion

This study suggests that chronic GLP-1 agonist use does not lead to inferior short-term outcomes or long-term PROMs following lumbar fusion. GLP-1 agonists may benefit the return of bowel function, potentially due to chronic gut motility adaptations and/or anti-inflammatory properties. Further study is required to support these findings.